Clinical Trial Update: Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

View source ↗

Summary

This clinical trial update reports demographics, compliance, tolerability, and safety data for patients with rheumatoid arthritis, psoriatic arthritis, and anky…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Status: COMPLETED | Results posted: 2012-12-05